查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1608144

颅内支架总覆盖市场：按类型、应用和最终用户划分 - 2025-2030 年全球预测

Intracranial Stents Total Addressable Market by Type (Balloon Expanding Stents, Self-Expanding Stents, Stent-Assisted Coil Embolization), Application (Brain Aneurysm, Intracranial Stenosis), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年颅内支架市场总价值为29.2亿美元，预计到2024年将达到30.4亿美元，复合年增长率为5.61%，到2030年将达到42.8亿美元。

颅内支架是透过支撑薄弱的血管壁、增加血流量和防止大脑潜在阻塞来治疗脑血管疾病的重要装置。该市场包括不同类型的支架，包括为各种神经手术（例如动脉瘤修復和缺血性中风恢復）设计的自动扩张型支架和球囊扩张型支架。由于神经系统疾病盛行率上升、世界人口老化以及高血压和糖尿病等文明病（增加中风风险）的发病率增加，对这些支架的需求更加突出。它们的应用范围广泛，包括医院、神经科科诊所和门诊手术中心，反映了它们在先进医疗干预和长期患者照护中的重要作用。影响该市场的关键成长要素包括技术创新，例如提高灵活性的支架设计进步和最大限度减少潜在副作用的涂层材料。此外，医疗保健支出的增加、中风预防的意识以及微创手术的进步也进一步推动了市场的成长。机会在于扩大术后护理的远端医疗、透过生物材料研究加强支架设计以及进入医疗需求未满足的新兴市场。然而，市场成长面临严格的法规环境、支架手术的高成本以及缺乏熟练的专业人员来处理复杂的神经介入等挑战。供应链中断和竞争压力也加剧了市场限制。最佳创新领域包括具有用于即时监测的整合感测器的智慧支架，以及开发个人化医疗策略以根据个别患者的需求量身定制治疗方案。了解这些动态至关重要，因为颅内支架市场具有快速的技术进步和激烈的市场竞争，需要持续的研究和策略联盟来实现业务成长。这些见解可以帮助公司应对市场挑战，同时利用新兴的创新和业务扩张机会。

主要市场统计
基准年[2023] 29.2亿美元
预计年份 [2024] 30.4亿美元
预测年份 [2030] 42.8亿美元
复合年增长率（%） 5.61%

市场动态：快速发展的颅内支架综合市场的关键市场洞察

供需的动态交互作用正在改变整个颅内支架市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球颅内疾病盛行率不断上升
    • 微创颅内手术日益偏好
    • 提高诊断率
  • 市场限制因素
    • 颅内支架手术相关的副作用
  • 市场机会
    • 研究机构的新临床试验和研究
    • 持续的产品开发和增强
  • 市场挑战
    • 缺乏合格和熟练的专业人员

波特五力：驾驭整个颅内支架能力市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对整个颅内支架市场的影响

外部宏观环境因素在塑造颅内支架整体能力市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解所有颅内支架的市场竞争状况

对整个颅内支架覆盖市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV定位矩阵颅内支架全覆盖市场供应商的绩效评估

FPNV定位矩阵是评估颅内支架全覆盖市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘整个颅内支架市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对颅内支架全覆盖市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球颅内疾病盛行率增加
      • 人们对微创颅内手术的兴趣日益浓厚
      • 提高诊断率
    • 抑制因素
      • 颅内支架手术相关的副作用
    • 机会
      • 研究机构的新临床试验和研究
      • 持续的产品开发和增强
    • 任务
      • 缺乏合格和熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章颅内支架综合市场：依类型

  • 球囊扩张支架
  • 自动扩张型支架
  • 支架辅助弹簧圈栓塞术

第七章颅内支架综合市场：依应用分类

  • 脑动脉瘤
  • 颅内狭窄

第八章颅内支架总覆盖市场：依最终用户分类

  • 门诊手术中心
  • 医院

第9章：北美和南美颅内支架的整体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区颅内支架市场全覆盖

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲颅内支架综合市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Acandis GmbH
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • optimed Medizinische Instrumente GmbH
  • Sino Medical Sciences Technology Inc.
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-742BD517FF13

The Intracranial Stents Total Addressable Market was valued at USD 2.92 billion in 2023, expected to reach USD 3.04 billion in 2024, and is projected to grow at a CAGR of 5.61%, to USD 4.28 billion by 2030.

Intracranial stents are vital devices designed to treat cerebrovascular diseases by providing support to weakened blood vessel walls, facilitating blood flow, and preventing potential blockages within the brain. The scope of this market encompasses various stent types, including self-expanding and balloon-expandable stents, designed for diverse neurological procedures such as aneurysm repair and ischemic stroke recovery. The necessity of these stents is underscored by the rising prevalence of neurological disorders, an aging global population, and the increasing incidence of lifestyle-related conditions like hypertension and diabetes, which elevate stroke risks. Their application spans hospitals, specialized neurology clinics, and ambulatory surgical centers, reflecting their critical role in advanced medical interventions and long-term patient care. Key growth factors influencing this market include technological innovations, such as developments in stent design for improved flexibility and coating materials that minimize potential side effects. Furthermore, increased healthcare spending, awareness of stroke prevention, and advancements in minimally invasive procedures further bolster market growth. Opportunities lie in expanding telemedicine for aftercare, enhancing stent design through biomaterial research, and accessing emerging markets with unmet healthcare needs. Nevertheless, market growth faces challenges including stringent regulatory environments, the high cost of stent procedures, and limited skilled professionals for complex neurological interventions. Supply chain disruptions and competitive pressures also add to market constraints. The best areas for innovation involve the development of smart stents with integrated sensors for real-time monitoring and personalized medicine strategies that tailor treatments to individual patient needs. Understanding these dynamics is crucial as the intracranial stents market is characterized by rapid technological advancements and competitive intensity, necessitating continuous research and strategic partnerships for business growth. By leveraging these insights, firms can adeptly navigate market challenges while capitalizing on burgeoning opportunities for innovation and expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 2.92 billion
Estimated Year [2024] USD 3.04 billion
Forecast Year [2030] USD 4.28 billion
CAGR (%) 5.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intracranial Stents Total Addressable Market

The Intracranial Stents Total Addressable Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of intracranial disease across the globe
    • Rising preference for minimally invasive intracranial surgeries
    • Increase in number of diagnostic rates
  • Market Restraints
    • Associated adverse effects of intracranial stents surgeries
  • Market Opportunities
    • Emerging clinical trials and studies by research organizations
    • Ongoing product development and enhancement
  • Market Challenges
    • Lack of qualified and skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Intracranial Stents Total Addressable Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intracranial Stents Total Addressable Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intracranial Stents Total Addressable Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intracranial Stents Total Addressable Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intracranial Stents Total Addressable Market

A detailed market share analysis in the Intracranial Stents Total Addressable Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intracranial Stents Total Addressable Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intracranial Stents Total Addressable Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intracranial Stents Total Addressable Market

A strategic analysis of the Intracranial Stents Total Addressable Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intracranial Stents Total Addressable Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Johnson & Johnson Services, Inc., Medtronic PLC, MicroPort Scientific Corporation, optimed Medizinische Instrumente GmbH, Sino Medical Sciences Technology Inc., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Stents Total Addressable Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Balloon Expanding Stents, Self-Expanding Stents, and Stent-Assisted Coil Embolization.
  • Based on Application, market is studied across Brain Aneurysm and Intracranial Stenosis.
  • Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of intracranial disease across the globe
      • 5.1.1.2. Rising preference for minimally invasive intracranial surgeries
      • 5.1.1.3. Increase in number of diagnostic rates
    • 5.1.2. Restraints
      • 5.1.2.1. Associated adverse effects of intracranial stents surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging clinical trials and studies by research organizations
      • 5.1.3.2. Ongoing product development and enhancement
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of qualified and skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intracranial Stents Total Addressable Market, by Type

  • 6.1. Introduction
  • 6.2. Balloon Expanding Stents
  • 6.3. Self-Expanding Stents
  • 6.4. Stent-Assisted Coil Embolization

7. Intracranial Stents Total Addressable Market, by Application

  • 7.1. Introduction
  • 7.2. Brain Aneurysm
  • 7.3. Intracranial Stenosis

8. Intracranial Stents Total Addressable Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals

9. Americas Intracranial Stents Total Addressable Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intracranial Stents Total Addressable Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Stents Total Addressable Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acandis GmbH
  • 3. Johnson & Johnson Services, Inc.
  • 4. Medtronic PLC
  • 5. MicroPort Scientific Corporation
  • 6. optimed Medizinische Instrumente GmbH
  • 7. Sino Medical Sciences Technology Inc.
  • 8. Stryker Corporation
  • 9. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET RESEARCH PROCESS
  • FIGURE 2. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BALLOON EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STENT-ASSISTED COIL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY INTRACRANIAL STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET, FPNV POSITIONING MATRIX, 2023